Endotoxin OOS after line intervention – FDA/MHRA inspection outcome
The first step in addressing an endotoxin OOS event is recognizing the symptoms and signals that indicate a problem. Symptoms may include:Click to read the full article.
Manufacturing Defects
Fill volume variability during stability testing – FDA/MHRA inspection outcome
Recognizing symptoms of fill volume variability early is paramount. Common signals that may suggest a deviation include:Click to read the full article.
Sterility test failure after line intervention – patient safety risk analysis
Recognizing and documenting the initial signals of a sterility test failure is crucial for timely intervention. Symptoms can manifest in various forms, detailing the impact of operational deviations.Click to read…
Fill volume variability after line intervention – FDA/MHRA inspection outcome
Detecting fill volume variability typically begins with identifying key symptoms or signals during manufacturing processes. The following are common indicators of fill volume variability:Click to read the full article.
Visual inspection rejects post-sterile filtration – FDA/MHRA inspection outcome
Symptoms or signals indicating potential issues with visual inspection rejections can arise in several forms. These may include:Click to read the full article.
pH drift detected during aseptic filling – patient safety risk analysis
The first step in addressing any manufacturing deviation, such as pH drift, is identifying the specific symptoms observed during the filling process. Symptoms may include:Click to read the full article.
Particulate matter detected post-sterile filtration – CAPA effectiveness failure
Symptoms indicative of particulate matter detected post-sterile filtration might include:Click to read the full article.
CCIT failure post-sterile filtration – CAPA effectiveness failure
Understanding the symptoms and signals within your facility is crucial after a CCIT failure. Common indicators of a potential problem may include:Click to read the full article.
Media fill failure during stability testing – CAPA effectiveness failure
Identifying symptoms or signals associated with a media fill failure during stability testing is the first step in an effective deviation investigation. The following indications are pivotal during initial assessments:Click…
Visual inspection rejects during aseptic filling – FDA/MHRA inspection outcome
Detecting visual inspection rejects starts with observing symptoms both on the production floor and in quality control labs. Some common signals that suggest a potential issue include:Click to read the…
Visual inspection rejects during stability testing – patient safety risk analysis
Recognizing the symptoms or signals that indicate a potential issue is the first step in the investigation process. During stability testing, visual inspection may reveal various defects, including:Click to read…
Particulate matter detected during PAI readiness – patient safety risk analysis
The first step in addressing particulate matter detected during PAI readiness is identifying the symptoms. Symptoms may include:Click to read the full article.